Trials / Completed
CompletedNCT02186665
Plaque Psoriasis Study in Pediatric Subjects
A Multicenter, Randomized, Double Blind, Parallel Group, Vehicle Controlled, Study of the Safety and Efficacy of Calcitriol 3 mcg/g Ointment Applied Twice Daily for 8 Weeks in Pediatric Subjects (2 to 12 Years of Age) With Mild to Moderate Plaque Psoriasis
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 19 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 2 Years – 12 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the safety, efficacy and calcium metabolism of up to 8 weeks of treatment with calcitriol 3 mcg/g ointment versus its vehicle, when used twice daily, without occlusion, to treat children aged 2 to 12 years, with plaque psoriasis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | calcitriol ointment | |
| DRUG | placebo comparator |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2015-11-01
- Completion
- 2016-01-01
- First posted
- 2014-07-10
- Last updated
- 2021-02-18
- Results posted
- 2017-03-31
Locations
34 sites across 7 countries: United States, Belgium, Canada, Germany, Hungary, Italy, Spain
Source: ClinicalTrials.gov record NCT02186665. Inclusion in this directory is not an endorsement.